We suggest here, on the basis of previous and present findings, that both hs-cTnI and hs-cTnT can be used as a potent diagnostic biomarker for the assessment of left atrial enlargement and left ventricular hypertrophy. The gene discussed is TNNT2; the disease is left ventricular hypertrophy.